Type : Pyrrolidine, Purine
Chemical_Nomenclature : 4-[(2,6-dipyrrolidin-1-ylpurin-9-yl)methyl]phenol
Canonical SMILES : C1CCN(C1)C2=NC(=NC3=C2N=CN3CC4=CC=C(C=C4)O)N5CCCC5
InChI : InChI=1S\/C20H24N6O\/c27-16-7-5-15(6-8-16)13-26-14-21-17-18(24-9-1-2-10-24)22-20(23-19(17)26)25-11-3-4-12-25\/h5-8,14,27H,1-4,9-13H2
InChIKey : AHJLJZVXTRGSRD-UHFFFAOYSA-N
Other name(s) : 4-{[2,6-di(pyrrolidin-1-yl)-9H-purin-9-yl]methyl}phenol || Compound 3e
MW : 364.4
Formula : C20H24N6O
CAS_number :
PubChem : 154679136
UniChem : AHJLJZVXTRGSRD-UHFFFAOYSA-N
| Title : Development of 2,6,9-trisubstituted purines as neuroprotective agents targeting butyrylcholinesterase and cannabinoid CB2 receptor - Kordinova_2025_Eur.J.Med.Chem_301_118217 |
| Author(s) : Kordinova H , Mik V , Hemelikova N , Gonzalez G , Stepankova S , Gorova V , Bazgier V , Kvasnica M |
| Ref : Eur Journal of Medicinal Chemistry , 301 :118217 , 2025 |
| Abstract : |
| PubMedSearch : Kordinova_2025_Eur.J.Med.Chem_301_118217 |
| PubMedID: 41037984 |